| Literature DB >> 29859171 |
Takanori Takebe1, James M Wells2, Michael A Helmrath3, Aaron M Zorn4.
Abstract
The meteoric rise in stem-cell-derived organoid technologies has ushered in a new era of "organoid medicine." Here we discuss how an organoid center can accelerate the translation of laboratory proof-of-principle experiments into clinical practice by developing and utilizing shared platforms for commercial and medical applications.Entities:
Mesh:
Year: 2018 PMID: 29859171 PMCID: PMC8191130 DOI: 10.1016/j.stem.2018.05.008
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 25.269